In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Main Authors: | Sandra Silva-Arrieta, Philip J R Goulder, Christian Brander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-06-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1008607 |
Similar Items
-
Landscape and selection of vaccine epitopes in SARS-CoV-2
by: Christof C. Smith, et al.
Published: (2021-06-01) -
Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
by: Yazdani Z, et al.
Published: (2020-08-01) -
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
by: Zikun Yang, et al.
Published: (2021-02-01) -
In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19
by: Hüseyin Can, et al.
Published: (2020-12-01) -
A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
by: Manojit Bhattacharya, et al.
Published: (2020-01-01)